TuHURA BIOSCIENCES, INC./NV Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, issued for services for the quarter ending 2023-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, issued for services for the quarter ending 2023-03-31 was $110.00K.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, issued for services for the quarter ending 2020-03-31 was $4.00K, a 13.86% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, issued for services for the quarter ending 2019-12-31 was $3.00K, a 14.64% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, issued for services for fiscal 2023 was $110.00K.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, issued for services for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, issued for services for fiscal 2020 was $13.00K, a 5.64% decline from fiscal 2019.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, issued for services for fiscal 2019 was $13.78K, a 60.53% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | $110.00K 10-K · filed 2024-10-07 |
| 2023-03-31 | $110.00K 10-Q · filed 2023-05-11 | |
| 2021-06-30 | $0.00 10-K · filed 2021-09-28 | |
| 2020-06-30 | $13.00K 10-K · filed 2021-09-28 | |
| 2020-03-31 | $4.00K 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $3.00K 10-Q · filed 2021-05-13 | |
| 2019-09-30 | $5.00K 10-Q · filed 2021-05-13 | |
| 2019-06-30 | $13.78K 10-K · filed 2020-09-18 | |
| 2019-03-31 | $3.51K 10-Q · filed 2020-05-13 | |
| 2018-12-31 | $2.62K 10-Q · filed 2020-05-13 | |
| 2018-09-30 | $4.14K 10-Q · filed 2020-05-13 | |
| 2018-06-30 | $8.58K 10-K · filed 2019-09-09 | |
| 2017-06-30 | $564.00K 8-K · filed 2019-06-03 | |
| 2016-06-30 | $146.90K 10-K · filed 2017-09-27 | |
| 2015-06-30 | $181.19K 10-K · filed 2016-09-13 | |
| 2014-06-30 | $633.50K 10-K · filed 2015-11-16 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-28 | $1.04M 10-K · filed 2014-08-28 |
| 2013-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | |
| 2013-06-30 | $929.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | |
| 2013-03-31 | $68.56K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $75.80K 10-K · filed 2014-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |